ArticleBiotechnology reports (Amsterdam, Netherlands)2025

Glycoengineering of plant-produced Pembrolizumab enhances FcRn binding and extends serum half-life in mice.

Christine Joy I Bulaon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.